The Department of Medicine, through this program, invests in the career development of each Scholar, and is not limited to a specific research project or scholarly activity. Early Career Scholars will be expected to commit 75% of their effort to scholarly activities. The Outstanding Early Career Scholar Program will provide each Scholar with $75,000 annually for up to four years. These funds will only be used to support the career development, research, or innovative work of the Scholar. These funds cannot be used to support or supplement the Scholar’s salary. Progress will be evaluated every year.
Sridharan Raghavan, MD, PhD is an Assistant Professor of Medicine in the Division of Hospital Medicine and the Division of Biomedical Informatics and Personalized Medicine, and he is an attending physician in the Section of Hospital Medicine at the Rocky Mountain Regional VA Medical Center. His research focuses on precision medicine applied to type 2 diabetes—that is, how diabetes prevention and treatment can be individualized to maximize patient benefit and minimize harm. To that end, he uses large clinical databases and genetic data to better characterize the heterogeneity of type 2 diabetes patients in a way that can inform tailoring interventions and optimizing outcomes.
Dr. Raghavan will use this award to investigate how recent genetic advances involving diabetes and related cardiometabolic traits can be made clinically applicable using data from clinical biobanks and national genetic consortia. In addition to funding from the OECSP, he is the recipient of a VA Career Development Award.
Dates for Funding Cycles:
|January 1, 2021|
|Award Start Date||July 1, 2021|